The selectivity of BTZ for normal PBMCs compared with that for AML cells was greater than 2‐fold for Jurkat (10.2), KG‐1a (8.5), NB4 (4.6) and HL‐60 (3.0) cells, indicating good selectivity. This evidence concerns the gene CASC3 and acute myeloid leukemia.